BridgeBio Oncology Therapeutics, Inc. (BBOT): 4 filed Jan 5, 2026

Form type

4

Filing date

Jan 5, 2026

Accession number

0001193125-26-003027

Filer

BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)